Accelerometer Thresholds for Reducing GlycA and VLDL Biomarkers
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to provide specific physical activity thresholds for sedentary individuals to effectively reduce risks of diabetes, cardiovascular diseases, inflammations, cognitive impairments, and premature mortality, as existing guidelines are not suitable for sedentary populations and previous studies overestimate health status through subjective measures.
Innovation Solution
A method using motion sensors and transduction units to measure physical activity volume and intensity, determining that exceeding 2890 daily steps at acceleration classes 1.3-1.7 g significantly reduces blood glycoprotein acetylation (GlycA) and very low density lipoprotein particles (VLDLs), thereby establishing thresholds for reducing associated health risks.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current WHO physical activity guidelines (150 min moderate intensity per week) are applied to sedentary subjects, then general health recommendations are provided, but the guidelines are not achievable for sedentary populations and overestimate health status when based on subjective measures
Solution Approach 1:
The patent transforms physical activity measurement from subjective self-reported parameters to objective accelerometer-based parameters (acceleration in g, step count, time). This parameter change enables reliable assessment of actual physical activity levels in sedentary subjects, revealing that they perform far less activity than previously believed based on subjective measures.
2Measurement precision
If objective accelerometer measurement is used to assess physical activity, then accurate physical activity levels are revealed, but it shows that less than 5% of adults meet guidelines, exposing the large occurrence of sedentary lifestyle
Solution Approach 1:
The patent uses objective accelerometer measurement to provide accurate feedback on actual physical activity levels, revealing the true extent of sedentary behavior in populations. This feedback mechanism exposes the discrepancy between perceived and actual activity levels, enabling more accurate public health assessments.
3Adaptability or versatility
If physical activity thresholds are established for sedentary subjects to reduce health risks, then specific actionable guidelines are provided, but previous studies failed to provide such specific thresholds for sedentary populations
Solution Approach 1:
The patent performs preliminary research using objective measurement to establish specific physical activity thresholds (e.g., 2890 steps/day at acceleration 1.3-1.7 g) for sedentary subjects before these thresholds can be widely applied. This preliminary action fills the information gap about specific activity requirements for reducing health risks in sedentary populations.
4Measurement precision
If motion sensors and transduction units are used to measure physical activity volume and intensity, then exact thresholds for reducing GlycA and VLDLs are determined, but the device complexity increases
Solution Approach 1:
The patent uses motion sensors and transduction units as intermediary devices to objectively measure and quantify physical activity parameters (acceleration, steps, time). These intermediaries bridge the gap between physical activity behavior and health outcome assessment, enabling precise determination of activity thresholds without requiring complex direct measurement of biological markers.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides exact thresholds for physical activity that significantly lower GlycA and VLDLs in sedentary subjects, addressing the lack of specific guidelines for reducing chronic disease risks and premature mortality, demonstrating a novel and effective method for improving health outcomes in sedentary populations.
Implementation Method 1
The transduction unit registered accelerations of the body
Data Source
AI summary
Highblood levels of very low density lipoprotein lipids (VLDLs) and glycoprotein acyl (Glyc A) are known to increase risk of diabetes, cardiovascular diseases, inflammations, cognitive impairments, cancers and premature deaths in sedentary persons. The invention determines physical activity thresholds of daily steps and accelerations to reduce plasma concentrations of VLDLs and Glyc A. The method and device is an accelerometer recording and classifying numbers of steps and accelerations and comparing the person's steps and accelerations with those shown to reduce VLDLs and Gly A. The invention is characterized in that if the daily number of accleration maxima exceeds the given en threshold of 2980 steps in the acceleration range 1.3-1.7 g, the person has performed physical activity, typically known to reduce circulating VLDLs and Glyc A.